BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...
Human leukocyte antigen (HLA) genotyping is critical when preparing for stem cell transplants. The procedure is crucial to determine the genetic compatibility of the HLAs between the donor and ...
Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors The study included 17,292 unrelated ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(k) clearance by the United States Food and Drug ...
Tech-enabled transplant company CareDx announced a strategic partnership with Dovetail Genomics to push the next wave of innovation in human leukocyte antigen (HLA) genotyping for organ and stem cell ...
Despite advances in the field of organ transplantation, industry challenges such as a shortage of viable organs for transplantation remain. It’s an unfortunate truth: the number of patients who need ...
Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody, using a ...
• Preclinical data for a TCR-engineered T cell product specific for HLA-A*02:01/KRAS G12V. This is a crucial step to further broaden the patient population that could benefit from TCR-T therapies to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback